These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 27094392)
1. Early Paralysis for the Management of ARDS. Grawe ES; Bennett S; Hurford WE Respir Care; 2016 Jun; 61(6):830-8. PubMed ID: 27094392 [TBL] [Abstract][Full Text] [Related]
2. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey. Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426 [TBL] [Abstract][Full Text] [Related]
3. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient. deBacker J; Hart N; Fan E Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334 [TBL] [Abstract][Full Text] [Related]
4. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347 [TBL] [Abstract][Full Text] [Related]
5. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome. Mefford B; Donaldson JC; Bissell BD Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121 [No Abstract] [Full Text] [Related]
11. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Forel JM; Roch A; Marin V; Michelet P; Demory D; Blache JL; Perrin G; Gainnier M; Bongrand P; Papazian L Crit Care Med; 2006 Nov; 34(11):2749-57. PubMed ID: 16932229 [TBL] [Abstract][Full Text] [Related]
12. The use of paralytics in patients with acute respiratory distress syndrome. Hraiech S; Dizier S; Papazian L Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423 [TBL] [Abstract][Full Text] [Related]
13. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis. Li Bassi G; Gibbons K; Suen JY; Dalton HJ; White N; Corley A; Shrapnel S; Hinton S; Forsyth S; Laffey JG; Fan E; Fanning JP; Panigada M; Bartlett R; Brodie D; Burrell A; Chiumello D; Elhazmi A; Esperatti M; Grasselli G; Hodgson C; Ichiba S; Luna C; Marwali E; Merson L; Murthy S; Nichol A; Ogino M; Pelosi P; Torres A; Ng PY; Fraser JF; Crit Care; 2022 May; 26(1):141. PubMed ID: 35581612 [TBL] [Abstract][Full Text] [Related]
14. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome]. Lyu G; Wang X; Jiang W; Cai T; Zhang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261 [TBL] [Abstract][Full Text] [Related]
15. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Lyu T; Lee YS; Dhanvijay S; Freebairn R Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324 [TBL] [Abstract][Full Text] [Related]
16. Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network. Wongtangman K; Grabitz SD; Hammer M; Wachtendorf LJ; Xu X; Schaefer MS; Fassbender P; Santer P; Kassis EB; Talmor D; Eikermann M; Crit Care Med; 2021 Jul; 49(7):1137-1148. PubMed ID: 33710031 [TBL] [Abstract][Full Text] [Related]
17. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression. Shao S; Kang H; Tong Z BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180 [TBL] [Abstract][Full Text] [Related]
18. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials. Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488 [TBL] [Abstract][Full Text] [Related]
19. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis. Torbic H; Krishnan S; Harnegie MP; Duggal A Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506 [TBL] [Abstract][Full Text] [Related]
20. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome. Macario A; Chow JL; Dexter F BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]